Caxton Associates (New York)’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,284
Closed -$211K 392
2018
Q2
$211K Buy
+4,284
New +$243K 0.01% 349

Other funds holding ADNT

Caxton Associates (New York)'s ADNT Position: Q3 2018 in Review

Caxton Associates (New York) sold out of Adient (ADNT) in Q3 2018, closing a stake of 4,284 shares — an estimated $211K sold.

Caxton Associates (New York) first reported a position in ADNT in Q2 2018 and held it in 1 quarter. The position peaked at $211K in Q2 2018. 401 funds tracked by Wall St. Rank hold ADNT as of Q3 2018.

  • Caxton Associates (New York) reported no remaining Adient position as of Q3 2018 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,284 Adient shares in Q3 2018, an estimated $211K.
  • Caxton Associates (New York) first reported a position in Adient in Q2 2018 and held it in 1 quarter.
  • Caxton Associates (New York)'s Adient position peaked at $211K in Q2 2018.
  • 401 funds tracked by Wall St. Rank held Adient as of Q3 2018.

Based on Caxton Associates (New York)'s 13F filing for Q3 2018, filed 14 Nov 2018.